Miles Andrews

Dr. Miles Andrews is a Senior Research Fellow at Monash University and a Consultant Medical Oncologist at The Alfred Hospital, specializing in immuno-oncology and cancer therapy outcomes. He leads the Cancer and Host Dynamics Group, focusing on translational research in tumor-immune interactions, biomarkers of immunotherapy toxicity, and microbiome influences. His academic roles include NHMRC Early Career Fellowship and leadership in melanoma registry projects at WEHI. Dr. Andrews holds a PhD in genomics and melanoma biology from the University of Melbourne, complemented by postdoctoral research at the University of Texas MD Anderson Cancer Center.

• Education: PhD (University of Melbourne), Fellowship of the Royal Australasian College of Physicians (FRACP)
• Clinical Roles: Head of Immuno-oncology at The Alfred Hospital, Deputy Chair of Medical Oncology Discipline at Melanoma and Skin Cancer Trials Limited

Research interests span translational immuno-oncology, immune-related adverse events, and microbiome impacts on cancer therapy. His projects include biomarker development for immunotherapy toxicity, clinical trials for novel therapies, and integrative genomic analyses. Dr. Andrews has contributed to over 60 peer-reviewed publications and leads grants such as the NHMRC Equipment Grant for advanced imaging technology.

Scientific awards include the NHMRC Early Career Fellowship. He actively supervises trainees and chairs committees within Monash University's clinical schools. Current initiatives focus on androgen signaling modulation and combination therapies for treatment-resistant cancers.